Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
KSLM Radio | 1220 AM & 104.3 FM | Salem Oregon News Talk Radio
1+ hour, 35+ min ago (557+ words) The man died in Buta, the capital of Bas-Uele after traveling there from Isiro in Haut-Uele province, said Jean Kaseya, director general of Africa Centres for Disease Control and Prevention. The outbreak in eastern Congo, considered the fastest-growing one yet,…...
KSLM Radio | 1220 AM & 104.3 FM Salem, OR
1+ day, 1+ hour ago (17+ words) WHO says Congo’s Ebola outbreak is on track to surpass the deadliest one in history KSLM Radio...
The United Nations is worried about fertility
2+ week, 6+ day ago (96+ words) KSLM Radio (SRN NEWS)-After decades of promoting abortion and birth control to stem predicted overpopulation, the world body has finally noticed that birth rates are dropping in nearly every nation, threatening economic and societal ruin. The U.N. has issued a…...
Detransitioner Chloe Cole Testifies on Devastating Effects of Transition
2+ mon, 1+ week ago (34+ words) KSLM Radio Detransitioner Chloe Cole Testifies on Devastating Effects of Transition Published on June 3, 2026 at 5:15 PM Click play to listen live...
Akeso lung cancer drug helps patients live 15% longer than immunotherapy in China trial
2+ mon, 1+ week ago (538+ words) By Mariam Sunny and Kamal Choudhury May 31 (Reuters) – An experimental drug developed by China-based Akeso helped patients with advanced squamous non-small cell lung cancer live 15% longer than BeOne Medicines’ immunotherapy Tevimbra, and cut the risk of death by more than…...
AstraZeneca’s Imfinzi with pre-surgery drug boosts survival in bladder cancer trial
2+ mon, 4+ week ago (212+ words) May 14 (Reuters) – AstraZeneca said on Thursday that a late-stage trial of Imfinzi, combined with a targeted therapy prior to a surgery, showed significantly improved survival rate in patients with muscle-invasive bladder cancer. The Anglo-Swedish drugmaker, however, said overall survival from…...